These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 31369715

  • 1. Combretastatin-based compounds with therapeutic characteristics: a patent review.
    Nainwal LM, Alam MM, Shaquiquzzaman M, Marella A, Kamal A.
    Expert Opin Ther Pat; 2019 Sep; 29(9):703-731. PubMed ID: 31369715
    [Abstract] [Full Text] [Related]

  • 2. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
    Medarde M, Maya AB, Pérez-Melero C.
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agents.
    Mahal K, Biersack B, Schobert R.
    Int J Clin Pharmacol Ther; 2013 Jan 15; 51(1):41-3. PubMed ID: 23259996
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
    Mustafa M, Abdelhamid D, Abdelhafez EMN, Ibrahim MAA, Gamal-Eldeen AM, Aly OM.
    Eur J Med Chem; 2017 Dec 01; 141():293-305. PubMed ID: 29031074
    [Abstract] [Full Text] [Related]

  • 9. Development of combretastatins as potent tubulin polymerization inhibitors.
    Bukhari SNA, Kumar GB, Revankar HM, Qin HL.
    Bioorg Chem; 2017 Jun 01; 72():130-147. PubMed ID: 28460355
    [Abstract] [Full Text] [Related]

  • 10. Discovery and hit to lead optimization of novel combretastatin A-4 analogues: dependence of C-linker length and hybridization.
    Provot O, Hamze A, Peyrat JF, Brion JD, Alami M.
    Anticancer Agents Med Chem; 2013 Dec 01; 13(10):1614-35. PubMed ID: 24261611
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization.
    Cushman M, Nagarathnam D, Gopal D, Chakraborti AK, Lin CM, Hamel E.
    J Med Chem; 1991 Aug 01; 34(8):2579-88. PubMed ID: 1875350
    [Abstract] [Full Text] [Related]

  • 12. The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.
    González M, Ellahioui Y, Álvarez R, Gallego-Yerga L, Caballero E, Vicente-Blázquez A, Ramudo L, Marín M, Sanz C, Medarde M, Pelaéz R.
    Molecules; 2019 Nov 26; 24(23):. PubMed ID: 31779228
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure⁻Activity Relations of New Inhibitors of HDAC and/or Tubulin Function.
    Schmitt F, Gosch LC, Dittmer A, Rothemund M, Mueller T, Schobert R, Biersack B, Volkamer A, Höpfner M.
    Int J Mol Sci; 2019 Jan 17; 20(2):. PubMed ID: 30658435
    [Abstract] [Full Text] [Related]

  • 17. Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models.
    Reipsch F, Biersack B, Lucas H, Schobert R, Mueller T.
    Int J Mol Sci; 2021 Dec 03; 22(23):. PubMed ID: 34884888
    [Abstract] [Full Text] [Related]

  • 18. Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications.
    Karatoprak GŞ, Küpeli Akkol E, Genç Y, Bardakci H, Yücel Ç, Sobarzo-Sánchez E.
    Molecules; 2020 May 31; 25(11):. PubMed ID: 32486408
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.